CMRA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
CMRA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Comera Life Sciences Holdings's change in working capital for the quarter that ended in Sep. 2023 was $-0.04 Mil.
Comera Life Sciences Holdings's change in working capital for the fiscal year that ended in Dec. 2022 was $2.55 Mil.
It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).
The historical data trend for Comera Life Sciences Holdings's Change In Working Capital can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Comera Life Sciences Holdings Annual Data | |||||||
Trend | Dec20 | Dec21 | Dec22 | ||||
Change In Working Capital | -0.04 | 0.57 | 2.55 |
Comera Life Sciences Holdings Quarterly Data | |||||||||||
Dec20 | Jun21 | Sep21 | Dec21 | Mar22 | Jun22 | Sep22 | Dec22 | Mar23 | Jun23 | Sep23 | |
Change In Working Capital | Get a 7-Day Free Trial | 0.39 | 1.00 | 0.27 | 0.19 | -0.04 |
Change In Working Capital for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.41 Mil.
Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.
Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.
Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC
Consolidated Statements of Cash Flows | Fiscal Years Ended | January 31, | (Amounts in millions) |
Cash flows from operating activities: | 2014 | 2013 | 2012 |
Changes in certain assets and liabilities, net of effects of acquisitions: | |||
Receivables, net | (566) | (614) | (796) |
Inventories | (1,667) | (2,759) | (3,727) |
Accounts payable | 531 | 1,061 | 2,687 |
Accrued liabilities | 103 | 271 | (935) |
Accrued income taxes | (1,224) | 981 | 994 |
For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Comera Life Sciences Holdings's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.
Michael Gerard Campbell | officer: Chief Financial Officer | C/O COMERA LIFE SCIENCES HOLDINGS, INC., 12 GILL STREET, SUITE 4650, WOBURN MA 01801 |
Charles Cherington | 10 percent owner | ONE BOW STREET, CAMBRIDGE MA 02138 |
David Soane | 10 percent owner | C/O SOANE LABS, LLC, 380 NE 72ND TERRACE, MIAMI FL 33138 |
Robert Patrick Mahoney | officer: Chief Scientific Officer | 12 GILL STREET, SUITE 4650, WOBURN MA 01801 |
Barbara K Finck | director | C/O PROTINE DESIGN LAB, 3858 JACKSON ST, SAN FRANCISCO CA 94118 |
Kirsten Flowers | director | C/O KURA ONCOLOGY, INC., 12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO CA 92130 |
James Sherblom | director | 12 GILL STREET, SUITE 4650, WOBURN MA 01801 |
Stuart A Randle | director | 585 WEST 500 SOUTH, BOUNTIFUL UT 84010 |
Sullivan Edward Aloysius Jr. | director | 12 GILL STREET, SUITE 4650, WOBURN MA 01801 |
Sirshendu Roopom Banerjee | director | 12 GILL STREET, SUITE 4650, WOBURN MA 01801 |
Janice Mccourt | officer: Chief Business Officer | C/O COMERA LIFE SCIENCES HOLDINGS, INC., 12 GILL STREET, SUITE 4650, WOBURN MA 01801 |
Jeffrey S. Hackman | director, officer: See Remarks | 12 GILL STREET, SUITE 4650, WOBURN MA 01801 |
John D. Yee | director | 12 GILL STREET, SUITE 4650, WOBURN MA 01801 |
Neal Muni | officer: See Remarks | 12 GILL STREET, SUITE 4650, WOBURN MA 01801 |
Phoenix Venture Partners Lp | 10 percent owner | 36 DOCKSIDE CIRCLE, REDWOOD SHORES CA 94065 |
From GuruFocus
By Stock market mentor Stock market mentor • 01-05-2023
By sperokesalga sperokesalga • 04-27-2023
By Stock market mentor Stock market mentor • 01-04-2023
By Stock market mentor Stock market mentor • 01-12-2023
By Marketwired • 08-01-2023
By Marketwired • 07-20-2023
By Marketwired • 08-10-2023
By sperokesalga sperokesalga • 05-11-2023
By Business Wire Business Wire • 06-22-2022
By Value_Insider Value_Insider • 11-09-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.